Daily Mail | Developed cancer drug for 'western patients' who could afford, not 'for ... Times of India The Indian government gave local pharmaceutical house Natco Pharma a licence to produce a copy of Nexavar, used to treat liver and kidney cancer, at a 97% discount to the original selling price of the Bayer product in India. Global drugmakers say India ... Pharmaceutical chief tries to stop India replicating its cancer treatment Bayer CEO Marijn Dekkers said one of his firm's drugs was for 'western ... |
